Actively Recruiting

Phase Not Applicable
Age: 50Years - 85Years
All Genders
NCT06544564

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Led by BioLab Holdings · Updated on 2025-07-03

150

Participants Needed

9

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is designed to assess the clinical effectiveness of Membrane Wrap, a human amniotic membrane for the management of difficult to heal partial- or full-thickness venous leg ulcers (VLUs)

CONDITIONS

Official Title

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Who Can Participate

Age: 50Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ulcers must be of venous origin confirmed by clinical signs or tests
  • Ulcers must have lasted at least 1 month without adequate response to conventional therapy
  • Ulcer size between 2 cm² and 16 cm²
  • Ulcer area must not have decreased by 40% or more during the 2-week screening
  • Ulcers may be partial- or full-thickness involving epidermis and dermis
  • Participants must be between 50 and 85 years old
  • Participants must be available for 12-week follow-up
  • Participants or their legal representative must have signed informed consent
Not Eligible

You will not qualify if you...

  • Ankle Brachial Index less than 0.7 or Toe Brachial Index less than 0.5
  • Vasculitis, severe rheumatoid arthritis, or other collagen vascular diseases
  • Medical conditions impairing wound healing such as kidney, liver, blood, nerve, or immune diseases
  • Signs of infection, cellulitis, or bone infection (osteomyelitis)
  • Necrotic ulcer beds
  • Receiving hemodialysis or uncontrolled diabetes with A1C 12 or higher
  • Use of corticosteroids (>15 mg/day), immunosuppressants, radiation therapy, or chemotherapy within 1 month prior to study
  • Ulcer unable to be debrided or participant cannot tolerate debridement
  • Unwilling or unable to comply with compression therapy
  • Participation in other wound or device studies within past 3 months or 30 days respectively

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Tital Clinical Research

Mesa, Arizona, United States, 85202

Actively Recruiting

2

Center for Clinical Research

San Francisco, California, United States, 94115

Actively Recruiting

3

Midland Florida Clinical Research Center

DeLand, Florida, United States, 32720

Actively Recruiting

4

Biophase Research

North Miami Beach, Florida, United States, 33162

Actively Recruiting

5

Doctors Research Network

South Miami, Florida, United States, 33143

Actively Recruiting

6

Gateway Clinical Trials

O'Fallon, Illinois, United States, 62269

Actively Recruiting

7

Northwell Health

Lake Success, New York, United States, 11042

Actively Recruiting

8

Kent State College of Podiatry

Cleveland, Ohio, United States, 44013

Actively Recruiting

9

Advantage Foot Care of Houston

Houston, Texas, United States, 77074

Actively Recruiting

Loading map...

Research Team

M

Marshall Medley

CONTACT

C

Carlos Encinas

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here